Clinical Trials Insight: 700032832
Phase of Trial: Phase II
Latest Information Update: 22 Apr 2008
At a glance
- Drugs BHT 3009 (Primary)
- Indications Multiple sclerosis
- Focus Therapeutic Use
- Sponsors Bayhill Therapeutics
- 22 Apr 2008 New trial record.
- 17 Apr 2008 The trial is expected to commence later in 2009, according to a Bayhill Therapeutics media release.